Home / Available CME / 17th CROI eSymposium
Credit Designation
17th CROI eSymposium
Please Click Here to See Important Information Regarding the Pending Application with The European Union of Medical Specialists (UEMS)
Additional programming is available that will review the 17th CROI including Expert Poster Review and CME Newsletter. To view these additional programs please click the corresponding link below:
About the Program
- Program Overview
- Target Audience
- Learning Objectives
- Course Director and Moderator
- Faculty
- Accreditation Statement
- Credit Designation
- Disclosure of Conflicts of Interest
- Disclosure of Unlabeled Use
- Instructions for Participation and Credit
- Disclaimer
- Request for Program Slides and Review
Program Overview
This Web Symposium will review and discuss the key studies on antiretroviral therapy presented at the 17th Conference on Retroviruses and Opportunistic Infections.* The symposium will feature five well-known and recognized thought leaders in the HIV field, with four serving as presenting faculty/discussants and one as program moderator.
This program is certified for CME credit for US physicians by the Postgraduate Institute for Medicine. This program is for health care providers who treat HIV-positive patients, there are no prerequisites.
Program Note: An application has been submitted to the European Union of Medical Specialists (UEMS) for approval to provide direct EACCME accredited continuing medical education for European participants and is pending. Currently, participating non-US physicians can receive the specified number of AMA PRA Category 1 Credits specific to the program and have these converted to their national CME credit in their specific country, where applicable. Similarly, non-US health care providers other than physicians can receive a certificate of completion and use this to acquire national credit through their national continuing medical education board/association, where applicable. If you have any questions, please contact ViralEd at admin@viraled.com
Target Audience
This activity has been designed to meet the educational need of physicians involved in the care of patients with HIV infection.
Learning Objectives
Following this program, participants will be able to:
-
Explain the key new studies on ARV therapy presented at the 17th CROI;
-
Outline how to use the advances in clinical management of HIV-positive patients presented and discussed at the 17th CROI to improve patient care;
-
Describe how to apply data presented and discussed at the 17th CROI regarding the treatment of ARV-naïve and experienced patients;
-
Analyze treatment options and construct appropriate ARV regimens.
Release Date: February 25, 2010
Expiration Date: February 24, 2011
Estimated time to complete the 17th CROI Web Symposium: 1 hour 45 minutes
Media: Internet
Course Director and Moderator
John Bartlett, MD
Professor, Johns Hopkins University
School of Medicine
Baltimore, Maryland
Faculty
Jose Arribas, MD,
Senior Attending Physician, HIV Unit
Hospital de La Paz
Madrid, Spain
David Cooper, MD
Professor, University of New South Wales
Director of The National Centre in Epidemiology & Clinical Research
Sydney, Australia
Joseph Eron, MD,
Professor, University of North Carolina
School of Medicine
Chapel Hill, North Carolina
Jurgen Rockstroh, MD
Professor, University of Bonn
Bonn, Germany
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Dr. John Bartlett:
- Contracted Research: Tibotec
- Consulting Fees: Gilead; Merck; Sailient
Dr. Joseph Eron:
- Contracted Research: GlaxoSmithKline; Merck & Co.; Panacos; Taimed
- Consulting Fees: Bristol-Myers Squibb; Avexa; Merck & Co.; GlaxoSmithKline; Tibotec; Virco Laboratories; Pfizer; Tobira; Chimirex; Myriad
- Speakers' Bureau/Honorarium Agreements: Roche; Bristol-Myers Squibb; Gilead; Merck & Co.; Tibotec (Not Active Since 1/1/09; Virco Laboratories; Gilead (Not Active)
Dr. Jose Arribas:
- Consulting Fees: Merck & Co.; Tibotec; Janssen; Gilead; GlaxoSmithKline; Pfizer; Biogen; Avexa; Bristol-Myers Squibb
Dr. David Cooper:
- Consulting Fees: ViiV; Gilead; Merck & Co.; Tobira; Tibotec; Bristol-Myers Squibb
Dr. Juergen Rockstroh:
- Contracted Research: Abbott; Bristol-Myers Squibb; Boehringer Ingelheim; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead; Schering
- Consulting Fees: Abbott; Bristol-Myers Squibb; BI; Merck & Co.; Roche; GlaxoSmithKline; Pfizer; Gilead
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
The following PIM planners and managers: Jan Hixon, RN, BSN, MS, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interest related to the content of these activities of any amount during the past 12 months.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), ViralEd, LLC, and Merck & Co., Inc. do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, LLC, and Merck & Co., Inc. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the period, February 26, 2010 through February 25, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
You may complete the Post-test on-line at http://www.cmeuniversity.com/.
- Click on "Find Post-Test/Evaluation by Course" on the navigation menu
- Search by project ID 6874
- Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Request for Program Slides and Review
To request a copy of the program slides as well as further education on how to use the slides please CLICK HERE to fill out a content request form.
Supported by an educational grant from Merck & Co., Inc.
*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings
Share this page:
